Irdabisant (CEP-26401) is a potent, brain-penetrant H3 receptor inverse agonist with demonstrated in vivo efficacy, enhancing cognition and wakefulness in rodent models. It is a selective research tool for studying cognitive deficits associated with conditions like schizophrenia, showing low hERG channel affinity.